The global market for breast reconstruction is estimated to grow at a significant rate of 6.5% during the forecasted period and is expected to reach over 3.6 billion by 2026.
Continuously increasing prevalence of the breast cancer across the globe have increased the demand for the breast reconstruction treatment. The increasing numbers of women’s with genetic diseases as well as increasing healthcare expenditure by major economies across the world are the factors driving the growth of the breast reconstruction market. Additionally, the growing investments in R&D and increasing government support fosters the breast reconstruction market growth. According to American Cancer Society, about 1.7 million new cancer cases are expected to be diagnosed by the end of 2018 and approximately 609,640 Americans are expected to die of cancer in 2018 i.e. 1,670 deaths per day. Increasing spending on research and development has boosted the growth of the breast reconstruction market. Cancer Research UK have spent USD 518 million on cancer research across the U.K to accelerate progress and increase cancer surviving rate by 75% by 2034. The organization is also aiming to increase the proportion of GDP spend on R&D to 2.6% by 2023. Additionally, increasing per capita income of the people, favorable reimbursement policies, and increasing awareness about availability of treatment have supported the growth of breast reconstruction market.
On the other hand, several factors such as the high cost of treatment as well as the lack of skilled professionals are hindering the global breast reconstruction market growth during the forecast period 2019–2026.
The market research study on “Breast Reconstruction Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers a detailed outlook, strategic recommendations, and insightful viewpoints on the global Breast reconstruction market. The report also analyzes the key players operating in Breast reconstruction market and identifies the key strategies deployed by them along with the market share of leading players.
The global Breast reconstruction market is segmented as below:
Breast reconstruction Market By Product
Breast reconstruction Market By Shape
Breast reconstruction Market By End Users
Breast reconstruction Market By Geography
The global breast reconstruction market is segmented by product, shape, and end user.
On the basis of product, the breast reconstruction market is segmented into tissue expander, implants, silicone breast implants, and others.
Based on shape, the global breast reconstruction market is segmented into round, and anatomical.
Based on end user, the breast reconstruction market is segregated into hospitals, cosmetology clinics, and ambulatory surgical centers, and others.
The global breast reconstruction market is segmented on the basis of the region covering North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa (LAMEA).
North America is considered as the biggest market for breast reconstruction, owing to the advancements in the medical technology as well as the diagnostics and extensive use of new technologies. Moreover, the presence of major players also fuels the market growth. North America is one of the leading markets across the globe owing to high prevalence of breast cancers in region. According to the American Cancer Society, in 2016, over 15.5 million people survived of cancer and the number is expected to reach 20.3 million by 2026 in the U.S. Additionally, to meet the upcoming demand and grab the major share of the market, most of the key players are heavily investing in research and development activities and using modern technologies in R&D in this region which has supported the growth of the breast reconstruction market. Moreover, high spending power of the people will support the breast reconstruction market in North America.
The European market is driven by the increasing government support for research and development activities and the increasing prevalence of breast cancer. Considering the rapidly growing market, the growth is governed by the rising focus on research activities by key market players in the field of genetics and technological developments in Germany. Increasing government support and growing expenditure on R&D are projected to drive the Europe cancer stem cell market. France and Germany are the largest contributors to Europe market growth owing to increasing investments in health care and cancer research.
Asia Pacific market is driven by the rising awareness related to the research in cancer and the steady increase in the occurrence of genetic diseases. Countries such as Japan, China, and India are considered as the major countries contributing to the market growth, owing to the availability of research facilities. Additionally, the growth is attributed to the presence of skilled workforce such as several research scientists and others. Furthermore, the growing number of research institutes focusing on the diagnosis and treatment of breast cancer with the help of increasing availability of funds and breast reconstruction for research in the field maintains the growth of the breast reconstruction market.
The market in the Middle East and Africa is predicted to hold the limited share due to the rising demand for the poor economic condition, research activities and healthcare services, and less development in medical facilities, particularly in Africa. Latin American and the Middle Eastern countries including Saudi Arabia, United Arab Emirates (UAE), and Kuwait are projected to drive the LAMEA market as result of high spending of the people and growing healthcare sector. On the other hand, Africa is estimated to witness moderate growth and possessing a huge opportunity.
Some of the key players in the global breast reconstruction market include Mentor Worldwide LLC; POLYTECH Health & Aesthetics GmbH; Sientra, Inc.; Deal Implant Incorporated; Allergan Inc.; Establishment Labs S.A; GROUPE SEBBIN SAS; Integra LifeSciences Corporation;RTI Surgical Holdings, Inc.; and GC Aesthetics.